Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjuvant Therapy of Breast Cancer: Impact of Erythropoiesis Stimulating Factors on Event Free Survival High Risk Breast Cancer Treatment

NCT00309920 is registered in ClinicalTrials.gov with Heinrich-Heine University, Duesseldorf as lead sponsor.

NCT NCT00309920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00309920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjuvant Therapy of Breast Cancer: Impact of Erythropoiesis Stimulating Factors on Event Free Survival High Risk Breast Cancer Treatment
Lead sponsor
Heinrich-Heine University, Duesseldorf
Phase
Not applicable
Overall status
Unknown status
Start date
January 31, 2004
Completion date
Not reported
Enrollment
1,234 (estimated)
Sites
47

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer